Get started
Author

Sanyuan Sun

Observed names: S. Sun, S.C.C. Sun
ORCID: 0000-0001-9721-8513
Observed ORCID: 0000-0001-9721-8513
OpenAlex ID: A5101985286
ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancer
2025 · Xichun Hu, Qingyuan Zhang, et al. · Signal Transduction and Targeted Therapy · 43
PDF
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer
2019 · Youwei Zhang, Yang Li, et al. · Biomedicine & Pharmacotherapy · 26
PDF
SBF2‐AS1: An oncogenic lncRNA in small‐cell lung cancer
2019 · Youwei Zhang, Yang Li, et al. · Journal of Cellular Biochemistry · 24
Safety and Tolerability of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM-HNSCC)
2024 · A.D. Colevas, K. Kerrigan, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Exploring the Dosage of Asari Radix et Rhizoma in Traditional Chinese Medicine and its Application in Rheumatoid Arthritis
2023 · W. Jiang, S. Sun, et al. · Indian Journal of Pharmaceutical Sciences · 1
PDF
1339P Efficacy and safety of MIL60, a bevacizumab biosimilar, in combination with paclitaxel/carboplatin in patients with advanced or recurrent non-squamous non-small cell lung cancer: A randomized, double-blind, multicenter phase III study
2021 · J. Wang, R. Wang, et al. · Annals of Oncology · 1
57P Clinical characteristics and outcomes in non-small cell lung cancer (NSCLC) with tumour and germline BRCA1/2 mutations
2023 · G.N.J. Arthur, S. Sun · ESMO Open
PDF
Detection of Circulating Tumor DNA Correlates with Recurrence and Survival in Localized Non-Small-Cell Lung Cancer: A Meta-Analysis
2023 · W. Zhang, X. Yang, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Works count: 8
Citation count: 96
H-index: 3
I10-index: 3
Year
Topic
Type